Metformin in patients with and without diabetes: a paradigm shift in cardiovascular disease management
Abstract With an increasing global burden of coronary artery disease (CAD), early detection and timely management of risk factors are crucial to reduce morbidity and mortality in such patients. Diabetes mellitus (DM) is considered an independent risk factor for the development of CAD. Metformin, an...
Main Authors: | Fei Luo, Avash Das, Jingfei Chen, Panyun Wu, Xiangping Li, Zhenfei Fang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-04-01
|
Series: | Cardiovascular Diabetology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12933-019-0860-y |
Similar Items
-
Comparing Alterations of Blood Glucose Level in type II Diabetic Pa-tients Taking Metformin and Withhold of Metformin on the Morning of Coronary Artery Bypass Graft Surgery
by: M. Tarbiat, et al.
Published: (2016-09-01) -
Metformin as a medicine decreasing cardiovascular risk in patients suffering from type 2 diabetes mellitus
by: Małgorzata Wieteska, et al.
Published: (2020-08-01) -
Evaluation of the effect of metformin and insulin in hyperglycemia treatment after coronary artery bypass surgery in nondiabetic patients
by: Kamran Ghods, et al.
Published: (2017-01-01) -
Cardiovascular diabetology in the core of a novel interleukins classification: the bad, the good and the aloof
by: Motro Michael, et al.
Published: (2003-09-01) -
Metformin is not associated with lactic acidosis in patients with diabetes undergoing coronary artery bypass graft surgery: a case control study
by: Rakan I. Nazer, et al.
Published: (2017-05-01)